|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| Research and development | |||||
| General and administration | |||||
| Loss from operations | |||||
| Net finance income/(expense) | |||||
| Finance income | |||||
| Finance expense | |||||
| Movement of expected credit loss | |||||
| Foreign exchange gain/(loss) | |||||
| Total other income | |||||
| Loss before tax | |||||
| Tax charge/(credit) | |||||
| Loss for the year | |||||
| Other comprehensive (expense)/income | |||||
| Items that may be reclassified to profit or loss | |||||
| Fair value movement on marketable securities | |||||
| Currency translation adjustment | |||||
| Total comprehensive loss for the year | |||||
| Attributable to owners: | |||||
| Loss for the year | |||||
| Total comprehensive loss for the year | |||||
| Loss per share | |||||
| Basic loss per share (in dollars per share) | |||||
| Diluted loss per share (in dollars per share) | |||||
Loading...